Oncothyreon, a biotechnology company specialising in the development of therapeutic products for the treatment of cancer, has appointed Julie Eastland as chief financial officer (CFO) and vice president, corporate development. Eastland’s responsibilities will include financial management, investor relations and business development.
Eastland served as CFO and vice president finance and operations of VLST Corporation, a biotechnology company, from February 2006 to 2010. From 2000 to 2005, Eastland held various finance positions at Dendreon Corporation, a biotechnology company, most recently as the vice president of strategic planning.
Prior to Dendreon, Eastland worked for Amgen as area finance manager and assistant controller for its Colorado operations. She has also worked as director of finance and planning for Encore Media Group, international finance and business manager and senior financial analyst for SCIENCE Magazine, and financial manager for the Discovery Channel. Eastland received an MBA from Edinburgh University Management School and a BS in finance from Colorado State University.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more